These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12641782)

  • 1. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verrucous carcinoma arising within syringocystadenoma papilliferum.
    Monticciolo NL; Schmidt JD; Morgan MB
    Ann Clin Lab Sci; 2002; 32(4):434-7. PubMed ID: 12458900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin.
    Eckert F; Betke M; Schmoeckel C; Neuweiler J; Schmid U
    J Cutan Pathol; 1992 Aug; 19(4):294-301. PubMed ID: 1331211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed syringocystadenoma papilliferum and papillary eccrine adenoma occurring in a scrotal condyloma.
    Coyne JD; Fitzgibbon JF
    J Cutan Pathol; 2000 Apr; 27(4):199-201. PubMed ID: 10774942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syringocystadenoma papilliferum].
    Baino A; Akhdari N; Amal S; Hamdaoui A; Abbad F; Rais H
    Ann Dermatol Venereol; 2015; 142(6-7):460-2. PubMed ID: 25956460
    [No Abstract]   [Full Text] [Related]  

  • 13. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors.
    Katsumata M; Ezoe K
    J Dermatol; 1990 May; 17(5):307-11. PubMed ID: 2166096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenoma papilliferum of the eyelid.
    Perlman JI; Urban RC; Edward DP; Tso MO
    Am J Ophthalmol; 1994 May; 117(5):647-50. PubMed ID: 8172272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.